(Press-News.org) Oncology specialists from around the globe will gather for the American Society of Clinical Oncology (ASCO) Annual Meeting to discuss the latest cancer therapies, technologies, research and education.
The theme this year is Partnering With Patients: The Cornerstone of Cancer Care and Research. More than 30,000 people are expected to attend the meeting taking place in Chicago and online June 2-6, 2023.
“As the world’s leading clinical cancer meeting, ASCO is an important event for oncology professionals to share information on the latest developments and clinical advances,” said Alan Ashworth, PhD, FRS, president of the UCSF Helen Diller Family Comprehensive Cancer Center (HDFCCC) and senior vice president for cancer services with UCSF Health.
At the meeting, Ashworth will receive a special Science of Oncology Award for his innovative, translational achievements, including his work developing PARP inhibitors for cancer treatment.
One of the world’s preeminent cancer researchers and pioneer of targeted cancer therapy, Ashworth had a central role in the discovery of the BRCA2 genetic mutation, which is linked to a higher risk of some types of cancer. Ashworth also identified ways to exploit genetic weaknesses in cancer cells, including mutated BRCA1 or BRCA2 genes, giving rise to PARP inhibition as a new “synthetic lethal” approach to cancer treatment.
“The recipients of this year’s Special Awards have made outstanding contributions to the oncology community, leading a global effort to transform cancer care and improve the lives of people living with cancer,” said Lori J. Pierce, MD, past president of ASCO and chair of the Joint Special Awards Selection Committee. “It is our honor to recognize their commitment and dedication with the highest honors that ASCO awards every year.”
In addition, Emily K. Bergsland, MD, a gastrointestinal oncologist and director of the UCSF Center for Neuroendocrine Tumors, will be recognized as a Fellow of the American Society of Clinical Oncology (FASCO). The distinction is granted to ASCO members for “extraordinary volunteer service, dedication, and commitment to ASCO.” Bergsland specializes in the multidisciplinary care of patients with neuroendocrine cancers.
ASCO Global Oncology Young Investigator Awards are being given to oncologist Sarah Kutika Nyagabona, MD, MMed, and pathologist Asteria Kimambo, MD, MMed. Both are based at Muhimbili University of Health and Allied Sciences and are PhD scholars under the UCSF Global Cancer Program’s Cancer Research Training Program in Tanzania.
The Bradley Stuart Beller Endowed Merit Award is being presented to William C. Chen, MD, a UCSF radiation oncology resident. And Annual Meeting Merit Awards will be given to Jacqueline Aredo, MD, MS, resident in the UCSF School of Medicine, and Howard Lee, MD, a clinical fellow in the UCSF Division of Hematology/Oncology.
An estimated 5,500 abstracts were selected for publication or presentation at this year’s meeting, which will include research on immunotherapy, pancreatic cancer, breast cancer, and gastrointestinal cancer. Topics include optimizing care for patients, improving access to cancer care, and developing novel treatments.
Here are some featured presentations by UCSF:
Friday, June 2:
1 p.m. CDT New Partners for EGFR-Mutant Lung Cancer
Phase II trial of neoadjuvant osimertinib for surgically resectable EGFR-mutated non-small cell lung cancer.
Presenter: Jacqueline Aredo, MD, MS
Clinical Science Symposium
Abstract 8508
2:45 p.m. CDT Gastrointestinal Cancer – Gastroesophageal, Pancreatic, and Hepatobiliary
Targets and Triplets in Pancreaticobiliary Tumors
Discussant: Andrew H. Ko, MD, FASCO
Oral abstract session
Saturday, June 3:
8 a.m. CDT The Promise of Neoadjuvant Immunotherapy Across Solid Tumors
Biomarkers predicting response to 5 immunotherapy arms in the neoadjuvant I-SPY2 trial for early-stage breast cancer: Evaluation of immune subtyping in the response predictive subtypes.
Presenter: Denise Wolf, PhD
Clinical Science Symposium
Abstract 102
8 a.m. CDT Genitourinary Cancer – Kidney and Bladder
Enfortumab vedotin with or without pembrolizumab in patients who are cisplatin-ineligible with previously untreated locally advanced or metastatic urothelial cancer: Additional 3-month follow-up on cohort K data.
Presenter: Terence W. Friedlander, MD
Poster session
Abstract: 4568
Poster board: 60
8 a.m. CDT Genitourinary Cancer – Prostate, Testicular and Penile
Depth of PSA nadir and subsequent PSA progression-free survival in patients with high-risk biochemically relapsed prostate cancer: Results from the phase 3 PRESTO study.
Presenter: Rahul Raj Aggarwal, MD
Poster session
Abstract: 5077
Poster board: 171
8 a.m. CDT Digital histopathology-based multimodal artificial intelligence scores predict risk of progression in a randomized phase III trial in patients with nonmetastatic castration-resistant prostate cancer.
Presenter: Felix Y. Feng, MD
Poster session
Abstract: 5035
Poster board: 129
1:15 p.m. CDT Prevention, Risk Reduction, and Hereditary Cancer
Patient-level factors associated with the use of active surveillance: The Talking About Prostate Cancer Cohort
Presenter: Nita Mukand, PharmD, MBA, MPH
Poster session
Abstract: 10565
Poster board: 198
3 p.m. CDT Practicing in a Polarized Society: Ethics and Social Justice in Oncology
Ending Systemic Racism in Oncology: The Role and Responsibility of the Clinician
Speaker: Ana I. Velazquez Manana, MD, MSc
Education session
Sunday, June 4:
8 a.m. CDT Professional Development and Education Advances
The cognitive load of inpatient consults involving immune-related adverse events
Presenter: Sam Brondfield, MD, MA
Poster session
Abstract: 11033
Poster board: 486
9:45 a.m. CDT Pediatric Oncology 1
Microscopes to Molecular: Informing Treatment Approaches in Pediatric Rare Tumors
Discussant: Sabine Mueller, MD, PhD
Oral abstract session
9:45 a.m. CDT Are Big Data Smart Enough to Answer Questions in Central Nervous System Tumors?
Clinical and analytical validation of a targeted gene expression biomarker predicting meningioma outcomes and radiotherapy responses
Presenter: William Cheng Chen, MD
Abstract: 2009
9:45 a.m. CDT Clinical applications of large data sets to small neurons
Discussant: John Frederick de Groot, MD
Clinical Sciences Symposium
11:30 a.m. CDT Professional Development and Education Advances
Should I stay, or should I go? Factors associated with intent to leave academic oncology
Presenter: Ana I. Velazquez Manana, MD, MDc
Poster session
Abstract: 11004
Poster board: 457
1 p.m. CDT Plenary Session
PROSPECT: A randomized phase III trial of neoadjuvant chemoradiation versus neoadjuvant FOLFOX chemotherapy with selective use of chemoradiation, followed by total mesorectal excision for treatment of locally advanced rectal cancer
Alan P. Venook, MD, a UCSF medical oncologist with special expertise in colorectal and liver cancers, is an author of the abstract.
Abstract: LBA2
4:30 p.m. CDT Breast cancer – local/regional/adjuvant
Correlation of HER2 low status in I-SPY2 with molecular subtype, response, and survival
Presenter: Hope S. Rugo, MD, FASCO
Poster session
Abstract: 514
Poster board: 344
Monday, June 5:
8 a.m. CDT Structural Sexism and Cancer Care: The Effects on the Patient and Oncologist
Defining Structural Sexism in Oncology
Chair: Bridget P. Keenan, MD, PhD
Education session
9:45 a.m. CDT Science of Oncology Award and Lecture
Award Lecturer: Alan Ashworth, PhD, FRS
Tuesday, June 6:
8 a.m. CDT Highlights of Melanoma/Skin Cancers
Discussant: Katy K. Tsai, MD
Highlights of the Day Session #3
About UCSF Health: UCSF Health is recognized worldwide for its innovative patient care, reflecting the latest medical knowledge, advanced technologies and pioneering research. It includes the flagship UCSF Medical Center, which is a top-ranked specialty hospital, as well as UCSF Benioff Children’s Hospitals, with campuses in San Francisco and Oakland, Langley Porter Psychiatric Hospital and Clinics, UCSF Benioff Children’s Physicians and the UCSF Faculty Practice. These hospitals serve as the academic medical center of the University of California, San Francisco, which is world-renowned for its graduate-level health sciences education and biomedical research. UCSF Health has affiliations with hospitals and health organizations throughout the Bay Area. Visit https://www.ucsfhealth.org/. Follow UCSF Health on Facebook or on Twitter
###
Follow UCSF
ucsf.edu | Facebook.com/ucsf | Twitter.com/ucsf | YouTube.com/ucsf
END
UCSF Health Cancer experts featured at premier cancer meeting
2023-06-02
ELSE PRESS RELEASES FROM THIS DATE:
Multiple sclerosis more prevalent in Black Americans than previously thought
2023-06-02
Multiple sclerosis has traditionally been considered a condition that predominantly affects white people of European ancestry. However, a new analysis conducted by a North American team led by University of Maryland School of Medicine (UMSOM) researchers suggests that the debilitating neurological condition is more prevalent in Black Americans than once thought. It is also far more prevalent in Northern regions of the country including New England, the Dakotas, and the Pacific Northwest.
Findings from the new study were recently published in the journal JAMA Neurology.
“We found a much higher prevalence of multiple sclerosis in Black Americans than previously ...
Sensory adapted dental rooms significantly reduce autistic children’s physiological and behavioral stress during teeth cleanings
2023-06-02
New results from a study led by USC researchers at Children’s Hospital Los Angeles show that a sensory adapted dental clinic environment creates less distressing oral care experiences for autistic children. The open-access article is available today in JAMA Network Open.
“We’ve shown that the combination of curated visual, auditory and tactile adaptations — all of which are easily implemented, relatively inexpensive and don’t require training to safely use — led to statistically significant decreases in autistic children’s behavioral ...
Couples’ social networks took long-lasting hit during COVID
2023-06-02
Key takeaways:
A UCLA study shows that a the outset of the COVID-19 pandemic, social interactions, both virtual and in person, declined significantly for married couples.
The decline was found to be greater and more long-lasting for Black and Latino couples and lower-income couples than for white couples and wealthier couples.
The researchers suggest exploring new ways of protecting public health during crises that also help more vulnerable populations sustain meaningful relationships.
Following the lockdowns and restrictions on public gatherings in the early days of COVID-19, the social networks of white, ...
AI software can provide ‘roadmap’ for biological discoveries
2023-06-02
Predicting a protein’s location within a cell can help researchers unlock a plethora of biological information that’s critical for developing future scientific discoveries related to drug development and treating diseases like epilepsy. That’s because proteins are the body’s “workhorses,” largely responsible for most cellular functions.
Recently, Dong Xu, Curators Distinguished Professor in the Department of Electrical Engineering and Computer Science at the University of Missouri, and colleagues updated their protein localization prediction model, MULocDeep, ...
Study helps explain what drives psoriasis severity and offers clues as to how disease may spread to other body parts
2023-06-02
Beneath and beyond the reddish, flaky lesions that form in the skin of those with psoriasis, mild and severe forms of the disease can be told apart by the activity of key cells and signaling pathways, a new study shows.
Led by researchers at NYU Grossman School of Medicine, the study mapped hidden features of inflammation and how they compared in cases of increasing severity of psoriatic disease. The team’s findings may help explain how small areas of skin inflammation can have wide-ranging effects in other parts of the body. Up to one-fifth of those with the skin disease, the researchers note, ...
New study finds strengthening protection of existing parks is crucial for biodiversity conservation
2023-06-02
-With pictures-
In a new study, bioscientists argue that strengthening the protection given to areas already protected under law or by local communities is as critical for safeguarding biodiversity as creating new protected areas.
The research team, which included scientists from Durham University, National University of Singapore (NUS) and Princeton University, found that about 70 per cent of the roughly 5000 species analysed either have no apparent representation in protected areas, occur in protected areas that have been downgraded, downsized or degazetted, ...
Scientists reveal new details of cellular process which prevents spread of cancer
2023-06-02
Researchers have for the first time characterised a unique molecular mechanism of the early stages of programmed cell death or apoptosis, a process which plays a crucial role in prevention of cancer.
The study, which is published today (Friday 2nd June 2023) in Science Advances, was led by Dr Luke Clifton at the STFC ISIS Neutron and Muon Source (ISIS) in Oxfordshire, alongside co-lead Professor Gerhard Gröbner at the University of Umeå and partners at the European Spallation Source in Sweden. It is ...
Development of an AI-based mass spectrometric technique capable of determining the monomeric sequence of a polymer
2023-06-02
1. The National Institute for Materials Science (NIMS) has developed an AI-based mass spectrometric technique capable of determining the monomeric sequence of a polymer. This technique may be useful in gaining a deeper understanding of basic polymeric structures, facilitating the development of new materials and helping solve plastic recycling problems.
2. A polymer is a very large molecule composed of a chain of many (ranging from hundreds to hundreds of thousands) small molecules called monomers that are bonded together. Many common polymers (e.g., plastics and resins) are copolymers, consisting of several different types of monomers. During the copolymerization process, the monomers ...
Non-invasive treatment of uterine fibroids research project secures grant at Baton Rouge Health-Tech Catalyst Pitch Night
2023-06-02
BATON ROUGE – A collaboration among Dr. Frank Greenway of Pennington Biomedical Research Center, Dr. Beverly Ogden of Woman’s Hospital in partnership with LSU, and the University of Louisiana at Lafayette, was named as one of three award recipients at the Baton Rouge Health-Tech Catalyst Pitch Night. The team will investigate non-invasive treatment of uterine fibroids, or benign growths, such as leiomyomas or myomas, that development from the muscle tissue of the uterus.
“Fibroids are non-cancerous tumors in the wall of the uterus that are common, and can cause bleeding, pain, and infertility,” ...
nTIDE May 2023 Jobs Report: Job numbers rebound bringing people with disabilities close to previous high in employment
2023-06-02
East Hanover, NJ – June 2, 2023 – In a sharp reversal, employment indicators rebounded for people with disabilities in May, according to today’s National Trends in Disability Employment – semi-monthly update (nTIDE), issued by Kessler Foundation and the University of New Hampshire’s Institute on Disability (UNH-IOD). Employment appears to be remaining strong despite the threats to the labor market posed by the debt ceiling crisis and ongoing efforts to control inflation.
Month-to-Month nTIDE Numbers (comparing April 2023 to May 2023)
Based ...